In seeking to pinpoint why black or African-American scientists are less likely than their white counterparts to receive National Institutes of Health research funding, a group of researchers has identified early career publications as a likely contributor to the gap.
Researchers from Case Western Reserve University School of Medicine have shown that a single 'cocktail' of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic filariasis, commonly known as elephantiasis, than other standard two-drug combinations previously used in the global effort to eliminate this infectious disease. A combination of all three drugs given simultaneously had never been tested until now.
A single protein regulates a battery of key genes inside developing sperm, according to a new study out of Case Western Reserve University School of Medicine. Scientists discovered the protein -- called Dazl -- controls a network of genes essential for developing sperm to replicate and survive. The findings, published in Cell Reports, could lay the groundwork for future research into therapies for infertile men.
A new study by researchers from the University of California, Riverside, and the Rotterdam School of Management finds that fear of missing out motivates investors to give money early to startups with a disruptive vision. However, those backers are reluctant to invest too much in unproven ideas that might not take off. In other words, disruptive startups are more likely to raise money, but they receive smaller amounts than less-threatening ventures.
A recent study assessing the relationship between nursing specialty certification rates and surgical site infections (SSI) provides an innovative option for future research exploring relationships between nursing and hospital procedures and medical and/or surgical adverse events.
The European Academy of Cancer Sciences (EACS), an independent advisory body of medical specialists and researchers, has issued a position paper encouraging the European Union and its member states to formally launch a mission to boost and streamline cancer research. Published in Molecular Oncology, a journal of the Federation of European Biochemical Societies, the goal is to increase the societal impact of research by decreasing cancer incidence, increasing cure rate, improving health-related quality of life, and developing cost-effective cancer prevention and therapeutic strategies.
A recent study finds that the tool most often used to assess the efficiency of nonprofit organizations isn't just inaccurate -- it is negatively correlated with efficiency.
An analysis of UK newspaper reporting of the NHS Cancer Drugs Fund (CDF) between 2010 and 2015 shows that despite some critical analysis, the mostly positive stories are likely to have contributed to the CDF's continuation, despite mounting evidence of its ineffectiveness. Close to £1.4 billion in total has been spent through the CDF which has subsequently been reconfigured and is now under the control of the National Institute for Health and Care Excellence (NICE).
More than half of early-career scientists who received their first research project (R01) grants from the National Institute of Allergy and Infectious Diseases (NIAID) are successful in obtaining subsequent funding from the National Institutes of Health (NIH), according to a study published September 12 in the open-access journal PLOS ONE by Patricia Haggerty and Matthew Fenton of NIAID, an NIH institute.
The American Association for Cancer Research (AACR) releases its annual Cancer Progress Report highlighting how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer.